2/12
11:16 am
grfs
Grifols, S.A. (NASDAQ: GRFS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Low
Report
Grifols, S.A. (NASDAQ: GRFS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
2/11
02:17 pm
grfs
Inside Takeda’s Plasma-Derived Therapy Ecosystem [Forbes]
Low
Report
Inside Takeda’s Plasma-Derived Therapy Ecosystem [Forbes]
1/14
07:38 am
grfs
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease [Yahoo! Finance]
Low
Report
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease [Yahoo! Finance]
1/14
06:00 am
grfs
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
Low
Report
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
1/13
10:00 am
grfs
Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols
Low
Report
Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols